Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.
Chunying
C
Li
Kexin
K
Chen
Zhensheng
Z
Liu
Li-E
LE
Wang
Jeffrey E
JE
Gershenwald
Jeffrey E
JE
Lee
Victor G
VG
Prieto
Madeleine
M
Duvic
Elizabeth A
EA
Grimm
Qingyi
Q
Wei
D017209:Apoptosis; D001120:Arginine / Q000737:chemistry; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000235:genetics*; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D016158:Genes, p53; D006801:Humans; D008297:Male; D009687:Nuclear Proteins / Q000235:genetics*; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D011392:Proline / Q000737:chemistry; D012694:Serine / Q000737:chemistry; D012878:Skin Neoplasms / Q000235:genetics*; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*; D025521:Tumor Suppressor Proteins / Q000235:genetics*
C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; C495901:TP53 protein, human; C000606460:TP73 protein, human; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins; D012694:Serine; D001120:Arginine; D011392:Proline